154 related articles for article (PubMed ID: 37972699)
1. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
Yu Y; Liang C; Tang Q; Shi Y; Shen L
Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
[TBL] [Abstract][Full Text] [Related]
2. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
3. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
[TBL] [Abstract][Full Text] [Related]
4. Key m
Zhang Y; Qi C; Guo Y; Li X; Zhu Z
BMC Med Genomics; 2023 Dec; 16(1):314. PubMed ID: 38049811
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
[TBL] [Abstract][Full Text] [Related]
6. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
7. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.
Liang C; Wang S; Zhang M; Li T
J Thorac Dis; 2022 May; 14(5):1607-1619. PubMed ID: 35693610
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
[TBL] [Abstract][Full Text] [Related]
10. Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis.
Li S; Liu H; Ruan Z; Guo R; Sun C; Tang Y; Huang X; Gao T; Hao S; Li H; Song N; Su Y; Ning F; Li Z; Chang T
J Transl Med; 2023 Mar; 21(1):166. PubMed ID: 36864526
[TBL] [Abstract][Full Text] [Related]
11. Gene Alterations of N6-Methyladenosine (m
Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
[TBL] [Abstract][Full Text] [Related]
12. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
[TBL] [Abstract][Full Text] [Related]
13. The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model.
Fei L; Sun G; Sun J; Wu D
Bioengineered; 2022 Mar; 13(3):7622-7634. PubMed ID: 35263199
[TBL] [Abstract][Full Text] [Related]
14. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
15. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
Zhang T; Sheng P; Jiang Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
[TBL] [Abstract][Full Text] [Related]
16. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
[TBL] [Abstract][Full Text] [Related]
18. Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer.
Tan W; Liu S; Deng Z; Dai F; Yuan M; Hu W; Li B; Cheng Y
J Cancer Res Clin Oncol; 2023 Feb; 149(2):593-608. PubMed ID: 36048273
[TBL] [Abstract][Full Text] [Related]
19. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
